Table 3.
Results with IHP for patients with colorectal cancer liver metastases treated with IHP.
Treatment regimen | Numberof evaluable patients | CR | PR | Median PFS months |
---|---|---|---|---|
Overall | 114 | 2 | 67 | 7.0 |
59% | ||||
IHP–no HAI | 58 | 0 | 33 | 5.8 |
57% | ||||
IHP–HAI | 46 | 2 | 30 | 13.0 |
65% | ||||
IHP (TNF alone) | 10 | 0 | 4 | 3.0 |
IHP, isolated hepatic perfusion; PR, partial response; CR, complete response; TNF, tumor necrosis factor; HAI, hepatic artery infusion.